Cochrane Abstracts
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Monoamine Oxidase B Inhibitors Versus Other Dopaminergic Agents in Early Parkinson's Disease New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434934/all/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_New. Accessed 20 October 2021.
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434934/all/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_New. Accessed October 20, 2021.
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434934/all/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_New
Monoamine Oxidase B Inhibitors Versus Other Dopaminergic Agents in Early Parkinson's Disease New [Internet]. In: Cochrane Abstracts. [cited 2021 October 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434934/all/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New
ID - 434934
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434934/all/Monoamine_oxidase_B_inhibitors_versus_other_dopaminergic_agents_in_early_Parkinson's_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -
